Clonidine as a Treatment of Behavioural Disturbances in Autism Spectrum Disorder: A Systematic Literature Review.

Conclusion: Clonidine has a limited evidence base for use in the management of behavioural problems in patients with ASD. Most evidence originates from case reports. Given the paucity of pharmacological options for addressing challenging behaviours in ASD patients, a clonidine trial may be an appropriate and cost-effective pharmaceutical option for this population. PMID: 32405312 [PubMed]
Source: Journal of the Canadian Academy of Child and Adolescent Psychiatry - Category: Psychiatry Authors: Tags: J Can Acad Child Adolesc Psychiatry Source Type: research